Interferon-Γ Upregulates SOCS3 Expression to Reduce Cisplatin Chemoresistance in Non-Small Cell Lung Cancer A549 Cells

Chemotherapy: Open Access
doi 10.4172/2167-7700.1000205
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Suberoylanilide Hydroxamic Acid (SAHA) Changes microRNA Expression Profiles in A549 Human Non-Small Cell Lung Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2009English

Expression of Multidrug Resistance Proteins and Accumulation of Cisplatin in Human Non-Small Cell Lung Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2005English

Association of ATP7A Expression and in Vitro Sensitivity to Cisplatin in Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2010English

LncRNA BLACAT1 Is Involved in Chemoresistance of Non‑small Cell Lung Cancer Cells by Regulating Autophagy

International Journal of Oncology
Cancer ResearchOncology
2018English

Interferon-Γ Upregulates Expression of IFP35 Gene in HeLa Cells via Interferon Regulatory Factor-1

PLoS ONE
Multidisciplinary
2012English

Cisplatin, Vinblastine, and Bleomycin in Inoperable Non-Small Cell Lung Cancer.

Thorax
PulmonaryRespiratory Medicine
1985English

TopBP1 Contributes to the Chemoresistance in Non-Small Cell Lung Cancer Through Upregulation of P53

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Bioenergetics of Acquired Cisplatin Resistant H1299 Non-Small Cell Lung Cancer and P31 Mesothelioma Cells

Oncotarget
Oncology
2017English

Epigenetic Activation of FOXF1 Confers Cancer Stem Cell Properties to Cisplatin‑resistant Non‑small Cell Lung Cancer

International Journal of Oncology
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy